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The Brindley procedure consists of a stimulator for sacral anterior-root stimulation and a rhizotomy of the dorsal sacral roots to
abolish neurogenic detrusor overactivity. Stimulation of the sacral anterior roots enables micturition, defecation, and erections.
This overview discusses the technique, selection of patients and clinical results of the Brindley procedure. The Brindley procedure is
suitable for a selected group of patients with complete spinal cord injury and detrusor overactivity. Overall, the Brindley procedure
shows good clinical results and improves quality of life. However, to remain a valuable treatment option for the future, the
technique needs some adequate changes to enable analysis of the implanted parts, to improve revision techniques of the implanted
parts, and to abolish the sacral dorsal rhizotomy.
1. Introduction
The Brindley procedure consists of a stimulator for sacral
anterior-root stimulation (SARS) and a rhizotomy of the
dorsal sacral roots to abolish neurogenic detrusor overac-
tivity. Stimulation of the sacral anterior roots enables mic-
turition, defecation, and erections. The Brindley procedure
is suitable for a selected group of skeletally mature patients
with complete spinal cord injury and detrusor overactivity,
who do not respond adequately to conservative treatments
of the detrusor overactivity. Patients with severe autonomic
dysreflexia or detrusor-external sphincter dyssynergia will
benefit especially from the dorsal rhizotomy. Patients with
incomplete injury will lose their sensory function due to the
dorsal rhizotomy and have the risk to experience pain sen-
sation during stimulation due to an incomplete rhizotomy.
The technique, selection of patients, and clinical results are
discussed in this overview.
2. Brindley Stimulator
The Brindley system is composed of an external and
implanted part. The implanted part consists of electrodes,
connecting cables, and a receiver block. Patients have to
position an external stimulating device on the skin over the
implanted receiver to evoke stimuli. The receiver does not
have a battery. Electrical stimuli are evoked by radiofre-
quency waves. With the availability of separate stimulation of
the sacral levels and various stimulation settings, it is possible
to set various stimulation programs to optimize micturition,
defecation, and penile erections.
A tripolar electrode cuﬀ is used for intradural stimula-
tion of the sacral anterior roots. A three-channel implant
is composed of two books. The upper book contains three
parallel slots for S3 (one slot) and S2 roots (two slots at
one channel), and the lower contains one slot for S4 roots.
Each slot contains one cathode in the centre and an anode at
each of the two ends to avoid stimulation of tissue structures
outside the slot. The two-channel implant allows stimulation
of two root levels or sets of root levels. The four-channel
implant has the same configuration as the three-channel
implant but allows independent stimulation of four sets of
roots. The choice for the number of channels depends on
the number of diﬀerent rootlet combinations that have to be
stimulated. Each channel is connected to the subcutaneous
receiver block by a silicone-coated cable.
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Extradural electrodes are used in patients in whom
intradural electrodes could not be placed due to, for example,
arachnoiditis or a previous intradural electrode implantation
that failed. Some centres prefer to use extradural electrodes
primarily for nearly all patients. The extradural implant has
three helical electrodes at its end, which are also configured
with a cathode between two anodes.
3. Poststimulus Voiding
Most of the small diameter parasympathetic eﬀerent nerve
fibres for innervation of the bladder are located in the sacral
anterior roots (S2–S4/5). Small-diameter nerve fibres need
a higher stimulus for their excitation than large-diameter
fibres. Consequently, electrical stimulation of the anterior
roots for detrusor contractions also causes contraction of
the urethral sphincter due to stimulation of somatic large-
diameter nerve fibres. This prevents emptying of the bladder.
To overcome this problem, poststimulus voiding is used. The
time to relax of striated muscles of the urethral sphincter
is shorter than the relaxation time of smooth muscles of
the detrusor. When intermittent stimulation pulse trains
are applied, the diﬀerence in muscle relaxation time can be
used to achieve a sustained detrusor muscle contraction with
intervals of urethral sphincter relaxation (Figure 1). These
intervals in between stimulations allow a decrease of the
urethral sphincter pressure while a high intravesical pressure
remains. This results in poststimulus voiding with an inter-
mittent pattern of the micturition flow. A comparable mech-
anism has been used for defecation.
4. Dorsal Rhizotomy of the Sacral Nerves
Sauerwein structurally expanded SARS with a dorsal rhi-
zotomy (deaﬀerentation) of sacral roots S2 till S5 [1].
A dorsal rhizotomy is important because it suppresses neuro-
genic detrusor overactivity and detrusor-external sphincter
dyssynergia [1, 2]. This results in a low-pressure bladder
without reflex contractions of the detrusor and subsequently
continence. Moreover, it reduces autonomic dysreflexia [2,
3]. Therefore, a dorsal rhizotomy can also be applied in
combination with intermittent catheterization to empty the
bladder without implantation of a Brindley stimulator [3].
5. Patient Selection
Patients need to have intact eﬀerent nerve pathways to the
bladder and a bladder that is able to contract. Contractions
of at least 50 cm H2O in males or 30 cm H2O in females need
to be present during filling cystometry [4]. If no suﬃcient
spontaneous contraction occurs, suitable patients can be
selected by rectal stimulation according to electroejaculation
procedures or direct needle stimulation of the sacral roots to
provoke bladder contractions.
Preoperative magnetic resonance imaging is used to
exclude arachnoiditis at the level of the conus and cauda
equine or other neurological disorder of the spinal cord.
Patients with active or previous arachnoiditis are not suitable
for intradural electrode implantation.
6. Implantation
A laminectomy from L3-L4 to S1-S2 is done for an intradural
rhizotomy and intradural implantation of the electrode cuﬀ.
The dura and arachnoid are opened at midline to expose the
sacral nerve roots. The anterior and dorsal components of
the roots, especially relevant anterior roots for micturition,
can be identified intradurally by electrical stimulation of
these components while monitoring the eﬀects on detru-
sor activity, blood pressure, and somatomotor responses.
A rhizotomy of the identified dorsal sacral roots is done.
The anterior sacral roots are positioned into the electrode
cuﬀ. The connecting cables are subcutaneously tunnelled to
a subcutaneous pocket for the receiver.
Implantation of extradural electrodes requires a laminec-
tomy from L5-S1 to S3-S4. The dorsal rhizotomy is done
at the level of the ganglia of S2-S5. Electrical stimulation
tests are used to identify the anterior and dorsal components
of the sacral roots. The extradural electrode is implanted
and fixated to the nerve using a strip of silicone rubber
sheet which is sewn to itself and surrounds the nerve. The
connecting cables and the receiver are implanted the same
way as the intradural procedure.
7. Clinical Results
Table 1 shows an overview of publications on the clinical
results of the Brindley procedure [3–20]. These results com-
prise both the Brindley stimulator, which enables stimulation
for micturition, defecation, and erections, and the dorsal
rhizotomy to achieve continence. The use of the Brindley
procedure for micturition and defecation, and the ability
to evoke erections are summarised in Figure 2, including
urinary continence rates. No accumulation of results is
possible due to the overlap of results of several reports,
especially the multicentre reports.
The Brindley stimulator is used for micturition in 73%
to 100% of patients during followup. These are considerable
percentages, but it should be noted that this includes
patients who use additional methods to empty their bladder.
Additional methods comprise intermittent catheterization,
abdominal straining (Valsalva manoeuvre), abdominal com-
pression (Crede´ manoeuvre), or suprapubic tapping for
reflex contractions. Stimulation that is not always com-
pletely successful can be found back in the percentages
of patients that have less than 50 mL residual urine after
stimulation for micturition. These percentages are lower
than the percentages of patients that use the stimulator for
micturition. Overall, the percentages of patients having
urinary tract infections and the frequency of urinary tract
infections decrease after the Brindley procedure compared to
the preoperative treatment.
The Brindley stimulator is used for defecation in 29% to
100% of patients in diﬀerent degrees. Not all patients achieve
complete evacuation of defecation using only stimulation.
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Figure 1: Example of poststimulus voiding using a Brindley stimulator. The three upper traces show the intravesical (Pves), intra-abdominal
(Pabd), and detrusor (Pdet) pressures during stimulation with a Brindley stimulator. The increase in EMG signal reflects the activation of
the stimulus during 5 seconds. Stimulation is activated every 12 seconds. The intermittent stimulation pattern allows the urethral sphincter
to relax while the detrusor pressure remains elevated. This results in an intermittent flow pattern.
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Figure 2: Results of the Brindley procedure on micturition, conti-
nence, defecation, and erections are summarised.
Some patients need laxatives in addition to prevent con-
stipation or enable defecation. Many patients only use the
stimulator to get the defecation into the rectum, to enable
digital evacuation.
Erections can be evoked in a substantial number of
patients, but results vary considerably. This can be explained
by the relatively low number of patients that actually use the
stimulator to evoke erections for sexual intercourse (0–
32%), due to qualitatively inadequate erections for sexual
intercourse or deterioration of the stimulation eﬀect over
time.
Autonomic dysreflexia mostly decreased after the Brind-
ley procedure as a result of the dorsal rhizotomy. Only a few
studies reported stimulation-induced autonomic dysreflexia.
Continence is achieved in 57% to 100% of patients,
and bladder capacity increased. However, continence is not
only achieved by a dorsal rhizotomy. Results on continence
also included additional treatments, like anticholinergics and
stress incontinence surgery.
8. Discussion
The ultimate treatment of neurogenic disorders of the lower
urinary tract would be resolvement of the neurogenic disor-
der that causes the bladder problems to restore the innerva-
tion of the bladder. As long as this causal treatment is not
available, symptomatic treatment options are required.
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Intravesical Botulinum toxin A injections are an evolving
option in the current treatment arsenal. At the time when
this paper was written, approval for urological application
was expected within short time. However, the Brindley pro-
cedure has several advantages for suitable patients compared
to Botulinum toxin A in combination with intermittent
catheterization, especially if not only the urological prop-
erties of the treatments are taken into account. Spinal cord
injury comprises a variety of coherent, physical problems.
Therefore, management of multiple organ dysfunctions
should be advocated. The Brindley procedure does not only
enable continence and micturition, but also complete defeca-
tion or improvement of defecation pattern, penile erections,
and reduction of autonomic dysreflexia and spasms. Patients
become less dependent because they do not need assistance
for intermittent catheterization anymore and can empty
their bladder whereever and whenever. When the treatment
options are discussed with a patient, this more extensive
application of the Brindley procedure should be mentioned.
The Brindley procedure generally shows good clinical
results for restoration of function in spinal cord injury
patients with multiple organ dysfunction, including bladder,
bowel, and erectile dysfunction. Moreover, the Brindley
procedure improves quality of life [20, 21]. However, it is not
a procedure that is easy to apply in clinical practice. Firstly,
not every patient is suited for the procedure and the success
depends on selection of appropriate patients. Prerequisites
are a complete spinal cord lesion since neurostimulation
can cause pain in incomplete spinal cord lesions, an intact
sacral motor neuron pathway enabling stimulation of the
bladder, and a detrusor muscle that is capable to contract on
stimulation. Secondly, a dorsal rhizotomy and implantation
of a Brindley stimulator is complex and not a routine pro-
cedure for urologists and should be reserved for specialized
centres. Thirdly, the technique is also prone to failures,
including the external and implanted components. Analysis
of the external components is easy to apply. Currently, a
straightforward solution for analysis and revision of the
implanted system without major surgery is not available in
every country. This can be explained by national legislation
with respect to certain aspects of the surgical procedure
for revision of the implant, like burning the insulation of
the implanted electrode cables. This excludes these patients
from the thorough analysis of the implanted components
and revision surgery to restore function of their stimulator.
Nowadays, most patients have become increasingly familiar
with intermittent catheterization and bowel rinsing. They
accept the dysfunction of the stimulator more frequently
because they remain continent due to their dorsal rhizotomy
in combination with controlled emptying of their bladder
and bowels.
A main issue for patients who consider a Brindley proce-
dure is the irreversibility of the rhizotomy, and the possibility
that future treatment options are not within reach anymore.
Although SARS can restore penile erections after a rhizo-
tomy, qualitative useful stimulation of erections is not possi-
ble in a substantial number of patients. Therefore, the dorsal
rhizotomy should be replaced by a less invasive procedure
to abolish detrusor overactivity. Continuous or conditional
neuromodulation could be one of the solutions [22, 23].
Sacral posterior- and anterior- root stimulation combines
neuromodulation and SARS without a rhizotomy of the
dorsal roots for micturition. These new developments are,
however, not generally introduced as a standard treatment.
Sacral posterior and anterior root stimulation eﬀectively
suppress DO but do not result in complete emptying in
all patients due to persisting detrusor-external sphincter
dyssynergia [24]. This requires development of techniques
that prevent backward stimulation when the anterior roots
are stimulated to enable selective detrusor stimulation, like
selective anodal block and high-frequency block [25–28].
9. Conclusion
The Brindley procedure shows good clinical results and
improves quality of life. However, to remain a valuable treat-
ment option for the future, the technique needs some ade-
quate changes to enable analysis of the implanted parts, to
improve revision techniques of the implanted parts, and to
abolish the sacral dorsal rhizotomy.
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